Dataset for The cost of delivering COVID-19 vaccines in the Kampala

This was a retrospective, bottom-up costing study that estimated the financial and economic costs of delivering C19 vaccines in the Ugandan capital city, Kampala. The study examines the initial vaccination rollout period in March and June 2021 (Phase 1) when priority populations were targeted, and the higher-volume period in July and December 2021 (Phase 2) when the target population was extended to the general population. Phase 1 also includes the preparation period between January 2021 and February 2021. Cost data were collected retrospectively between May 2023 and July 2023 from a sample of 28 public, private for profit (PFP), and private not for profit (PNFP) health facilities covering the five divisions that comprise Kampala. The sample also included the respective division offices, KCCA headquarters, and implementing partners directly supporting KCCA. Costs were disaggregated across program activities and resource types to analyze cost drivers. Volume-weighted average unit costs were estimated for each administrative level and then aggregated to obtain the overall volume-weighted cost per dose. Alongside the costing exercise, a qualitative assessment examined how the program was implemented, obtained lessons learned, and mapped key funding flows.

本研究为一项回顾性、自下而上的成本核算研究，旨在估算乌干达首都坎帕拉市新冠（C19）疫苗接种工作的财务与经济成本。研究涵盖两个接种阶段：其一为2021年3月至6月的首批疫苗推广接种期（第一阶段），彼时接种对象限定为优先人群，该阶段同时包含2021年1月至2月的筹备阶段；其二为2021年7月至12月的高规模接种期（第二阶段），此时接种范围扩展至全人群。
研究团队于2023年5月至7月间通过回顾性方式收集成本数据，样本覆盖坎帕拉市下辖5个行政区的28家公立、营利性私立（Private for Profit，PFP）及非营利性私立（Private Not for Profit，PNFP）医疗卫生机构。样本同时纳入各行政区办事处、坎帕拉首都区政府（Kampala Capital City Authority，KCCA）总部，以及直接为KCCA提供支持的项目执行伙伴。
研究按项目活动与资源类型对成本进行拆分，以剖析成本驱动因素。针对各行政层级估算剂量加权平均单位成本，随后汇总得到单剂疫苗的整体加权总成本。
本研究在开展成本核算的同时，还通过质性评估考察了项目的实施流程、总结了实践经验与教训，并梳理了关键资金流向。